The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials

In patients with ischaemic cardiomyopathy and severely reduced left ventricular ejection fraction (LVEF), an arrhythmogenic milieu is created by a complex interplay between myocardial scarring (assessed by cardiac MRI) and multiple other factors (ventricular ectopy, ischaemia and autonomic imbalance...

Descripción completa

Detalles Bibliográficos
Autores principales: Haanschoten, Danielle, Elvan, Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Clinical Arrhythmias
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576491/
https://www.ncbi.nlm.nih.gov/pubmed/34777819
http://dx.doi.org/10.15420/aer.2021.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576491/
https://www.ncbi.nlm.nih.gov/pubmed/34777819
http://dx.doi.org/10.15420/aer.2021.23

Ejemplares similares